Status:
NOT_YET_RECRUITING
Intravesical BCG: is the Urinary Bladder Ready to Receive it
Lead Sponsor:
Tata Memorial Centre
Conditions:
Non-Invasive Bladder Urothelial Carcinoma
Eligibility:
All Genders
Brief Summary
Prospective cohort and Prospective observational study which aims To define the healing time-frame of the resected area of the bladder after TURBT. and also to validate a grading system of healing of ...
Detailed Description
This study will be offered to patients who are coming to Tata Memorial Hospital (TMH) for management of Non Muscular Invasive bladder cancer. 10 patients who undergo Transurethral resection of Bladder...
Eligibility Criteria
Inclusion
- Patients undergoing complete TURBT for evaluation of a newly diagnosed bladder lesion in TMH and found to have NMIBC (either low risk or high risk) Patient gives consent will be included (after explaining about the study).
Exclusion
- Patient who has visible tumor on first or any subsequent cystoscopy.
- On histopathology found to have muscle invasive bladder cancer.
- Patient having urinary tract infection before cystoscopy
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05335512
Start Date
September 1 2022
End Date
September 1 2028
Last Update
June 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.